Literature DB >> 24604060

The role of brain tumor advocacy groups.

Michele Rhee1, Paulius Mui, Carl Cadogan, Jonny Imerman, Sarah Lindsell, Lainey Titus Samant.   

Abstract

The brain tumor community is a unique, underserved population that has not seen significant improvements in survival over the last four decades. In the search for effective treatments for brain tumors, nonprofit patient advocacy organizations identify and fill the gaps that the for-profit sector and the government have not addressed or cannot address. Although many articles have been written on the roles of patient advocacy groups in general, or in targeted areas such as clinical trial recruitment, none have looked at the brain tumor community specifically. This review looks at the literature on patient advocacy groups and provides specific examples of brain tumor advocacy organizations that offer these services. It examines the evolution of the role of these organizations over time, and how that has been reflected in the programs and services provided. This is a collaborative effort to highlight programs and services across multiple patient advocacy organizations.

Entities:  

Mesh:

Year:  2014        PMID: 24604060     DOI: 10.1007/s11910-014-0442-z

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  26 in total

1.  Professional organizations and their role in advocacy.

Authors:  Paula Trahan Rieger; Pearl Moore
Journal:  Semin Oncol Nurs       Date:  2002-11       Impact factor: 2.315

Review 2.  Advocacy groups as research organizations: the PXE International example.

Authors:  Sharon F Terry; Patrick F Terry; Katherine A Rauen; Jouni Uitto; Lionel G Bercovitch
Journal:  Nat Rev Genet       Date:  2007-02       Impact factor: 53.242

3.  The role of patient advocacy/parent support groups.

Authors:  Judith G Hall
Journal:  S Afr Med J       Date:  2013-10-11

4.  Empowerment of patients: lessons from the rare diseases community.

Authors:  Ségolène Aymé; Anna Kole; Stephen Groft
Journal:  Lancet       Date:  2008-06-14       Impact factor: 79.321

5.  Generating sociability to drive science: patient advocacy organizations and genetics research.

Authors:  Aaron Panofsky
Journal:  Soc Stud Sci       Date:  2011-02       Impact factor: 3.885

Review 6.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009.

Authors:  Therese A Dolecek; Jennifer M Propp; Nancy E Stroup; Carol Kruchko
Journal:  Neuro Oncol       Date:  2012-11       Impact factor: 12.300

7.  Policy and advocacy in the quest for effective translational breast care research.

Authors:  Marie M La Fargue
Journal:  Breast       Date:  2010-04-15       Impact factor: 4.380

8.  The impact of parent advocacy groups, the Internet, and social networking on rare diseases: the IDEA League and IDEA League United Kingdom example.

Authors:  Angela P Black; Marie Baker
Journal:  Epilepsia       Date:  2011-04       Impact factor: 5.864

Review 9.  The role of patient advocacy organizations in shaping genomic science.

Authors:  Pei P Koay; Richard R Sharp
Journal:  Annu Rev Genomics Hum Genet       Date:  2013-07-12       Impact factor: 8.929

10.  An essential partnership: patient advocates and cooperative groups.

Authors:  Deborah Collyar
Journal:  Semin Oncol       Date:  2008-10       Impact factor: 4.929

View more
  2 in total

1.  Collaboration for rare disease drug discovery research.

Authors:  Nadia K Litterman; Michele Rhee; David C Swinney; Sean Ekins
Journal:  F1000Res       Date:  2014-10-31

2.  Bridging evidence, policy, and practice to strengthen health systems for improved maternal and newborn health in Pakistan.

Authors:  Atsumi Hirose; Sarah Hall; Zahid Memon; Julia Hussein
Journal:  Health Res Policy Syst       Date:  2015-11-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.